EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Heterogeneous efflux pump expression underpins phenotypic resistance to antimicrobial peptides

Ka Kiu Lee iD, Urszula Łapińska, Giulia Tolle, Maureen Micaletto, Bing Zhang, Wanida Phetsang, Anthony D Verderosa, Brandon M Invergo, Joseph Westley, Attila Bebes, Raif Yuecel, Paul A O'Neill und 8 weitere

eLife · 2025

DOI: 10.7554/elife.99752 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Ka Kiu Lee und 19 weiteren Autor:innen. Beteiligte Einrichtung: Living Systems Institute, University of Exeter, Exeter, United Kingdom. Hauptthemen laut MEDLINE: Escherichia coli, Pseudomonas aeruginosa, Antimicrobial Peptides, Drug Resistance, Bacterial. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, Engineering and Physical Sciences Research Council, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance threatens the viability of modern medical interventions. There is a dire need to develop novel approaches to counter resistance mechanisms employed by starved or slow-growing pathogens that are refractory to conventional antimicrobial therapies. Antimicrobial peptides have been advocated as potential therapeutic solutions due to the low levels of genetic resistance observed in bacteria against these compounds. However, here we show that subpopulations of stationary phase Escherichia coli and Pseudomonas aeruginosa survive tachyplesin treatment without acquiring genetic mutations. These phenotypic variants display enhanced efflux activity to limit intracellular peptide accumulation. Differential regulation of genes involved in outer membrane vesicle secretion, membrane modification, and protease activity was also observed between phenotypically resistant and susceptible cells. We discovered that the formation of these phenotypic variants could be prevented by administering tachyplesin in combination with sertraline, a clinically used antidepressant, suggesting a novel approach for combatting antimicrobial-refractory stationary phase bacteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia coliPseudomonas aeruginosaAntimicrobial PeptidesDrug Resistance, BacterialAnti-Bacterial AgentsPeptides, CyclicAntimicrobial Cationic PeptidesMicrobial Sensitivity TestsGene Expression Regulation, BacterialSertralinePhenotypeMicrobial Viability

Stichwörter der Autor:innen

E. coliantibiotic accumulationantibioticsantimicrobial peptidesantimicrobial resistanceefflux pump inhibitorsefflux pumpsgene expressionheterogeneityinfectious diseasemembrane transportmicrobiologymicrofluidicsphysics of living systemsstationary phase

Substanzen

Antimicrobial PeptidesAnti-Bacterial AgentsPeptides, CyclicSertralineAntimicrobial Cationic Peptides

Autor:innen und Institutionen

  • Living Systems Institute, University of Exeter, Exeter, United Kingdom.
  • Biosciences, University of Exeter, Exeter, United Kingdom.
  • Department of Life and Environmental Sciences, University of Cagliari, Cittadella Universitaria, Cagliari, Italy.
  • Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, Australia.
  • Process Integration and Predictive Analytics, PIPA LLC, Davis, United States.
  • Centre for Ecology and Conservation and Environment and Sustainability Institute, University of Exeter, Exeter, United Kingdom.

ORCID-Profile: Ka Kiu Lee, Benjamin E Housden, Krasimira Tsaneva-Atanasova, Stefano Pagliara

Förderung

  • Biotechnology and Biological Sciences Research Council
  • Engineering and Physical Sciences Research Council
  • Medical Research Council
  • Wellcome Trust
  • Living Systems Institute
  • QUEX Institute

Zitieren

APA

Lee, K. K., Łapińska, U., Tolle, G., Micaletto, M., Zhang, B., Phetsang, W., Verderosa, A. D., Invergo, B. M., Westley, J., Bebes, A., Yuecel, R., O'Neill, P. A., Farbos, A., Jeffries, A. R., van Houte, S., Caboni, P., Blaskovich, M. A. T., Housden, B. E., Tsaneva-Atanasova, K., & Pagliara, S. (2025). Heterogeneous efflux pump expression underpins phenotypic resistance to antimicrobial peptides. eLife. https://doi.org/10.7554/elife.99752

Vancouver

Lee KK, Łapińska U, Tolle G, Micaletto M, Zhang B, Phetsang W, et al. Heterogeneous efflux pump expression underpins phenotypic resistance to antimicrobial peptides. eLife. 2025. doi:10.7554/elife.99752

BibTeX
@article{Lee2025,
  author = {Lee, Ka Kiu and Łapińska, Urszula and Tolle, Giulia and Micaletto, Maureen and Zhang, Bing and Phetsang, Wanida and Verderosa, Anthony D and Invergo, Brandon M and Westley, Joseph and Bebes, Attila and Yuecel, Raif and O'Neill, Paul A and Farbos, Audrey and Jeffries, Aaron R and van Houte, Stineke and Caboni, Pierluigi and Blaskovich, Mark A T and Housden, Benjamin E and Tsaneva-Atanasova, Krasimira and Pagliara, Stefano},
  title = {Heterogeneous efflux pump expression underpins phenotypic resistance to antimicrobial peptides},
  journal = {eLife},
  year = {2025},
  doi = {10.7554/elife.99752}
}
Kostenlos starten →